Notice: This company has been marked as potentially delisted and may not be actively trading. Revelation Biosciences (REVBU) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period REVB Results Set Stage for Future GrowthNovember 12, 2024 | msn.comWhy Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving PremarketNovember 11, 2024 | benzinga.comRevelation Biosciences (NASDAQ:REVB) Stock, Insider Trading ActivityOctober 4, 2024 | benzinga.comRevelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10September 24, 2024 | finance.yahoo.comBio-Techne Corporation (TE1.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comREVB Stock Earnings: Revelation Biosciences Misses EPS for Q2 2024August 9, 2024 | markets.businessinsider.comREVB: In Great Position For TestingMay 13, 2024 | msn.comREVB Begins Trials with Good Cash on HandMarch 25, 2024 | msn.comRevelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth ConferenceMarch 12, 2024 | finance.yahoo.comRevelation Biosciences starts phase 1 trial for GeminiMarch 6, 2024 | investing.comRevelation Biosciences (REVB) Price Target Increased by 242.79% to 40.04February 24, 2024 | msn.comRevelation Biosciences Inc Ordinary SharesFebruary 15, 2024 | morningstar.comRevelation Biosciences Regains Nasdaq Compliance with OfferingFebruary 9, 2024 | msn.comWhy Is Revelation Biosciences (REVB) Stock Up 61% Today?January 29, 2024 | markets.businessinsider.comRevelation Biosciences (REVB) Price Target Decreased by 23.67% to 11.68July 6, 2023 | msn.comRecap: Revelation Biosciences Q1 EarningsMay 22, 2023 | msn.comRevelation Biosciences Shares Drop 30% After Public Offering PricesFebruary 9, 2023 | marketwatch.com'UFOs are real!' Former Department of Defence official makes astonishing revelationJanuary 13, 2023 | mirror.co.ukRevelation Biosciences Inc. Announces Mandatory Unit Separation to Occur on January 13, 2023January 10, 2023 | finance.yahoo.comTrading was temporarily halted for "REVBU" at 09:07 AM with a stated reason of "LULD pause."July 28, 2022 | marketbeat.comTrading was temporarily halted for "REVBU" at 09:07 AM with a stated reason of "LULD pause."July 25, 2022 | marketbeat.comTrading was temporarily halted for "REVBU" at 09:07 AM with a stated reason of "LULD pause."July 25, 2022 | marketbeat.comTrading was temporarily halted for "REVBU" at 10:07 AM with a stated reason of "LULD pause."July 22, 2022 | marketbeat.comTrading was temporarily halted for "REVBU" at 10:07 AM with a stated reason of "LULD pause."July 22, 2022 | marketbeat.comTrading was temporarily halted for "REVBU" at 09:07 AM with a stated reason of "LULD pause."July 22, 2022 | marketbeat.comTrading was temporarily halted for "REVBU" at 03:04 PM with a stated reason of "LULD pause."April 8, 2022 | marketbeat.comTrading was temporarily halted for "REVBU" at 08:03 AM with a stated reason of "News pending."March 30, 2022 | marketbeat.comTrading was temporarily halted for "REVBU" at 12:03 PM with a stated reason of "LULD pause."March 9, 2022 | marketbeat.comTrading was temporarily halted for "REVBU" at 12:01 PM with a stated reason of "LULD pause."January 20, 2022 | marketbeat.com Get Revelation Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for REVBU and its competitors with MarketBeat's FREE daily newsletter. Email Address What Comes Next Could Be a Once-in-a-Lifetime Opportunity (Ad)A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come. Click here now to watch the full briefing and discover the steps to take today. REVBU Media Mentions By Week REVBU Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REVBU News Sentiment▼0.030.48▲Average Medical News Sentiment REVBU News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REVBU Articles This Week▼00▲REVBU Articles Average Week Get Revelation Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for REVBU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DRTSW News BCTXW News EFTRW News FBIOP News GOVXW News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REVBU) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revelation Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
